FDA approves first-of-a-kind flu vaccine made with animal cell technology
(Almost) Final setup with the new Drobo S by Glenn Batuyong
License (according to Flickr): Attribution License
License (according to Flickr): Attribution License
The Food and Drug Administration says it has approved the first seasonal flu vaccine made using animal cell technology, rather than the half-century egg method. The FDA approved Novartis' Flucelvax to prevent influenza in people 18 years and older. The new method has been promoted by U.S. health officials because it is faster than egg-based production and could speed up manufacturing in the event of a pandemic. In the older method, virus samples are injected into specialized chicken eggs and incubated. The egg fluids are later harvested, concentrated and purified into the vaccine. With cell technology, small amounts of virus are put in fermenting tanks with nutrients and cells derived from mammals. The virus is then inactivated, purified and put into vaccine vials.
FDA approves first-of-a-kind flu vaccine made with animal cell technology
Additional Info:
Drug: flu vaccine
Overall Sentiment: 0.145836
Relevance: 0.882561
HealthCondition: influenza
Overall Sentiment: 0.108174
Relevance: 0.359101
Disambiguation: DiseaseOrMedicalCondition | CauseOfDeath | InfectiousDisease | RiskFactor | DiseaseReferences:
Organization: Food and Drug Administration
Overall Sentiment: 0.180633
Relevance: 0.611966
Disambiguation: References:
Header Details
Site Provided Desc:
Webpage Provided Keywords:
Site Provided Title:
Source URL: Click Here
The Food and Drug Administration says it has approved the first seasonal flu vaccine made using animal cell technology, rather than the half-century egg method
Webpage Provided Keywords:
- Drug Administration
- flu
- flu vaccine
- Food and Drug Administration
- health
- Health officials
- influenza
- novartis
- technology
- U S
- virus
Site Provided Title:
FDA approves first-of-a-kind flu vaccine made with animal cell technology
Source URL: Click Here
No comments:
Post a Comment